Therapeutic applications of NSAIDS in cancer: Special emphasis on tolfenamic acid

Riyaz Mahammad Basha, C. T. Baker, Umesh Tanaji Sankpal, Sarfraz Ahmad, Stephen Safe, James L. Abbruzzese, Maen Abdelrahim

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are primarily used for the treatment of acute or chronic conditions with pain and inflammation. Evidence from a wide range of sources suggested that chronic administration of NSAIDs reduced the risk of cancer incidences. Both the epidemiological and animal studies showed an inverse association between the incidence of various cancers and the use of aspirin or other NSAIDs. The chemopreventive and therapeutic interventions of NSAIDs in cancer are obvious; however, the instigation of drug and treatment period depends on the study objective. Typically, prevention involves initiating the medication before the appearance of clinical symptoms and lasts longterm; while treatment could be short-term and contingent to the response of patient to the medication. Recent studies from our laboratories provided substantial evidence on the anti-cancer activity of tolfenamic acid, a NSAID for the potential applications in pancreatic, esophageal and lung cancers. In this review, we provide a summary on the potential benefits of NSAIDs in a variety of human cancers with more emphasis on tolfenamic acid.

Original languageEnglish
Pages (from-to)797-805
Number of pages9
JournalFrontiers in Bioscience - Scholar
Volume3 S
Issue number2
StatePublished - 1 Jan 2011

Fingerprint

Anti-Inflammatory Agents
Pharmaceutical Preparations
Neoplasms
Therapeutics
Incidence
Esophageal Neoplasms
tolfenamic acid
Pancreatic Neoplasms
Aspirin
Epidemiologic Studies
Lung Neoplasms
Animals
Inflammation
Pain

Keywords

  • Lung Cancer
  • NSAID
  • Pancreatic Cancer
  • Review
  • Sp1
  • Sp3
  • Tolfenamic Acid
  • Transcription Factors

Cite this

Basha, R. M., Baker, C. T., Sankpal, U. T., Ahmad, S., Safe, S., Abbruzzese, J. L., & Abdelrahim, M. (2011). Therapeutic applications of NSAIDS in cancer: Special emphasis on tolfenamic acid. Frontiers in Bioscience - Scholar, 3 S(2), 797-805.
Basha, Riyaz Mahammad ; Baker, C. T. ; Sankpal, Umesh Tanaji ; Ahmad, Sarfraz ; Safe, Stephen ; Abbruzzese, James L. ; Abdelrahim, Maen. / Therapeutic applications of NSAIDS in cancer : Special emphasis on tolfenamic acid. In: Frontiers in Bioscience - Scholar. 2011 ; Vol. 3 S, No. 2. pp. 797-805.
@article{009b4c93dd2e4bd7a8bc9374898430b9,
title = "Therapeutic applications of NSAIDS in cancer: Special emphasis on tolfenamic acid",
abstract = "Non-steroidal anti-inflammatory drugs (NSAIDs) are primarily used for the treatment of acute or chronic conditions with pain and inflammation. Evidence from a wide range of sources suggested that chronic administration of NSAIDs reduced the risk of cancer incidences. Both the epidemiological and animal studies showed an inverse association between the incidence of various cancers and the use of aspirin or other NSAIDs. The chemopreventive and therapeutic interventions of NSAIDs in cancer are obvious; however, the instigation of drug and treatment period depends on the study objective. Typically, prevention involves initiating the medication before the appearance of clinical symptoms and lasts longterm; while treatment could be short-term and contingent to the response of patient to the medication. Recent studies from our laboratories provided substantial evidence on the anti-cancer activity of tolfenamic acid, a NSAID for the potential applications in pancreatic, esophageal and lung cancers. In this review, we provide a summary on the potential benefits of NSAIDs in a variety of human cancers with more emphasis on tolfenamic acid.",
keywords = "Lung Cancer, NSAID, Pancreatic Cancer, Review, Sp1, Sp3, Tolfenamic Acid, Transcription Factors",
author = "Basha, {Riyaz Mahammad} and Baker, {C. T.} and Sankpal, {Umesh Tanaji} and Sarfraz Ahmad and Stephen Safe and Abbruzzese, {James L.} and Maen Abdelrahim",
year = "2011",
month = "1",
day = "1",
language = "English",
volume = "3 S",
pages = "797--805",
journal = "Frontiers in Bioscience - Scholar",
issn = "1945-0516",
publisher = "Frontiers in Bioscience",
number = "2",

}

Basha, RM, Baker, CT, Sankpal, UT, Ahmad, S, Safe, S, Abbruzzese, JL & Abdelrahim, M 2011, 'Therapeutic applications of NSAIDS in cancer: Special emphasis on tolfenamic acid', Frontiers in Bioscience - Scholar, vol. 3 S, no. 2, pp. 797-805.

Therapeutic applications of NSAIDS in cancer : Special emphasis on tolfenamic acid. / Basha, Riyaz Mahammad; Baker, C. T.; Sankpal, Umesh Tanaji; Ahmad, Sarfraz; Safe, Stephen; Abbruzzese, James L.; Abdelrahim, Maen.

In: Frontiers in Bioscience - Scholar, Vol. 3 S, No. 2, 01.01.2011, p. 797-805.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Therapeutic applications of NSAIDS in cancer

T2 - Special emphasis on tolfenamic acid

AU - Basha, Riyaz Mahammad

AU - Baker, C. T.

AU - Sankpal, Umesh Tanaji

AU - Ahmad, Sarfraz

AU - Safe, Stephen

AU - Abbruzzese, James L.

AU - Abdelrahim, Maen

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Non-steroidal anti-inflammatory drugs (NSAIDs) are primarily used for the treatment of acute or chronic conditions with pain and inflammation. Evidence from a wide range of sources suggested that chronic administration of NSAIDs reduced the risk of cancer incidences. Both the epidemiological and animal studies showed an inverse association between the incidence of various cancers and the use of aspirin or other NSAIDs. The chemopreventive and therapeutic interventions of NSAIDs in cancer are obvious; however, the instigation of drug and treatment period depends on the study objective. Typically, prevention involves initiating the medication before the appearance of clinical symptoms and lasts longterm; while treatment could be short-term and contingent to the response of patient to the medication. Recent studies from our laboratories provided substantial evidence on the anti-cancer activity of tolfenamic acid, a NSAID for the potential applications in pancreatic, esophageal and lung cancers. In this review, we provide a summary on the potential benefits of NSAIDs in a variety of human cancers with more emphasis on tolfenamic acid.

AB - Non-steroidal anti-inflammatory drugs (NSAIDs) are primarily used for the treatment of acute or chronic conditions with pain and inflammation. Evidence from a wide range of sources suggested that chronic administration of NSAIDs reduced the risk of cancer incidences. Both the epidemiological and animal studies showed an inverse association between the incidence of various cancers and the use of aspirin or other NSAIDs. The chemopreventive and therapeutic interventions of NSAIDs in cancer are obvious; however, the instigation of drug and treatment period depends on the study objective. Typically, prevention involves initiating the medication before the appearance of clinical symptoms and lasts longterm; while treatment could be short-term and contingent to the response of patient to the medication. Recent studies from our laboratories provided substantial evidence on the anti-cancer activity of tolfenamic acid, a NSAID for the potential applications in pancreatic, esophageal and lung cancers. In this review, we provide a summary on the potential benefits of NSAIDs in a variety of human cancers with more emphasis on tolfenamic acid.

KW - Lung Cancer

KW - NSAID

KW - Pancreatic Cancer

KW - Review

KW - Sp1

KW - Sp3

KW - Tolfenamic Acid

KW - Transcription Factors

UR - http://www.scopus.com/inward/record.url?scp=79955954938&partnerID=8YFLogxK

M3 - Article

C2 - 21196413

AN - SCOPUS:79955954938

VL - 3 S

SP - 797

EP - 805

JO - Frontiers in Bioscience - Scholar

JF - Frontiers in Bioscience - Scholar

SN - 1945-0516

IS - 2

ER -